4 healthcare AI trends: CVS Health data scientist shares details
Eugenio Zuccarelli, an innovation data scientist at Rhode Island-based CVS Health, didn’t set out on a career in AI because he wanted to work in healthcare. He simply wanted to do...
Category: Industry News
Unlocking linked real-world data presents opportunities to improve public health
The COVID-19 pandemic has surfaced the potential and risks of linked real word datasets to accelerate and produce new improvements in public health. In this post, Matthew Franklin, Dan Howdon, Suzanne Mason, Tony Stone, Monica...
Cancer Moonshot meeting brings together survivors, industry leaders
The gathering, convened by patient advocacy group Fight Colorectal Cancer, responded to President Biden’s call to improve screening and treatment options. Read More: https://www.outsourcing-pharma.com/Article/2022/07/26/cancer-moonshot-meeting-brings-together-survivors-leaders?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright
Another Battleground Takes Shape in Europe: Real-World Evidence
The scope of RWE’s use in developing and approving new medicines is pitting key healthcare stakeholders against each other. It’s been coming for years, but now it’s starting to bite....
Biden to tap prominent Harvard cancer surgeon to head National Cancer Institute
President Joe Biden is expected to pick cancer surgeon Monica Bertagnolli as the next director of the National Cancer Institute (NCI). Bertagnolli, a physician-scientist at the Dana-Farber Cancer Institute in...
Global regulators call for international collaboration to integrate real-world evidence into regulatory decision-making
EMA has endorsed a joint statement calling for international collaboration to enable the generation and use of real-world evidence for regulatory decision-making published today by the International Coalition of Medicines Regulatory Authorities (ICMRA)....
EMA joins regulatory coalition in calling for RWE to be integrated into regulatory decisions
As more and more biotechs are looking into the potential applications of using real-world evidence in regulatory submissions, the European Medicines Agency is calling for more widespread adoption. EMA endorsed...
Aligning Shared Evidentiary Needs Among Payers and Regulators for a Real-World Data Ecosystem
Executive Summary In the face of rapid innovation, a strong need exists for improved evidence generation capabilities to answer critical questions faced by regulators and payers. Systematically collecting real-world data...
Advancing real-world evidence for pharmaceutical companies in Japan
By Raymond Chan, Tsubasa Itani, Tomoko Nagatani, Michele Raviscioni, and Atsushi Sorita Pharmaceutical companies have long been using real-world evidence (RWE) to inform their decision making, respond to requests from external stakeholders, improve their...
Capturing real-world data and evidence in clinical trials
At UCB, we see the many benefits of integrating technology in all aspects of our business to amplify the power of scientific innovation and to improve patient care. In the...